Table 3.

ARHGAP11B expression in TCGA cancers.

Cancer type	Fold change	log2 (fold change)	Mean TPM (tumor)	Mean TPM (normal)	P value	Adjusted P value
Breast invasive carcinoma	4.69	2.23	480.03	102.32	3.77e‐50	7.52e‐49
Pan-kidney cohort (KICH+KIRC+KIRP)	2.95	1.56	135.41	45.88	1.36e‐47	2.28e‐46
Lung squamous cell carcinoma	8.44	3.08	766.07	90.72	1.96e‐31	1.3e‐29
Kidney renal clear cell carcinoma	2.74	1.45	160.72	58.66	1.78e‐30	1.49e‐29
Lung adenocarcinoma	4.35	2.12	394.06	90.63	1.77e‐27	2.56e‐26
Stomach and esophageal carcinoma	4.08	2.03	1000.62	245.54	1.53e‐23	4.71e‐21
Liver hepatocellular carcinoma	6.27	2.65	235.47	37.56	1.91e‐23	7.06e‐22
Uterine corpus endometrial carcinoma	6.59	2.72	511.13	77.58	2.15e‐20	8.37e‐19
Stomach adenocarcinoma	3.78	1.92	922.81	244.37	2.99e‐17	5.44e‐15
Head and neck squamous cell carcinoma	2.24	1.16	760.27	339.19	1.39e‐14	2.1e‐13
Kidney renal papillary cell carcinoma	2.7	1.43	84.99	31.48	1.21e‐12	8.74e‐12
Colon adenocarcinoma	1.89	0.92	770.75	406.89	8.73e‐11	2.47e‐10
Kidney chromophobe	5.51	2.46	160.32	29.09	1.58e‐10	1.34e‐9
Bladder urothelial carcinoma	2.55	1.35	579.21	227.08	2.56e‐8	3.52e‐7
Esophageal carcinoma	4.71	2.23	1174.79	249.58	2.92e‐7	2.7e‐05
Prostate adenocarcinoma	1.64	0.71	95.69	58.33	3.5e‐7	1.1e‐06
Cholangiocarcinoma	4.78	2.26	273.22	57.11	1e‐05	5.3e‐05
Cervical squamous cell carcinoma and endocervical adenocarcinoma	29.52	4.88	936.65	31.73	0.0029	0.0418
Thyroid carcinoma	1.14	0.19	84.17	73.93	0.0035	0.00518
Rectum adenocarcinoma	1.47	0.56	722.45	491.06	0.0352	0.0595

TMP: Transcript per million.